Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Biphentin Dosing and Monitoring Guidelines for ADHD

Starting Dose

  • Initiate Biphentin at 10 mg once daily in the morning for children aged ≥ 6 years, adolescents, and adults; titration should be based on clinical response rather than body weight. 1

Titration Schedule

  • Increase the dose by 10 mg increments at weekly intervals until optimal symptom control is achieved without intolerable adverse effects. 1
  • Maintain a minimum of 7 days between dose adjustments to allow adequate assessment of response. 1
  • In urgent clinical situations, the interval may be shortened to 3 days, although this approach is not preferred. 1
  • Continue titration until the maximum therapeutic benefit is reached or adverse effects become limiting. 1
  • The full titration process typically spans several weeks to months. 1

Maximum Dose

  • The usual maximum dose is 60 mg per day; higher doses may be employed when clinically justified, provided careful monitoring is in place. 1

Monitoring Requirements During Titration

  • Collect standardized ADHD rating scales from both parents and teachers before each dose increase to objectively assess response. 1
  • Measure blood pressure and pulse at each dose adjustment. 2
  • Assess weight at every visit as an objective indicator of appetite suppression. 1
  • Conduct weekly telephone or in‑person contacts during active titration to monitor progress and side effects. 1

Critical Pitfalls to Avoid

  • Do not calculate doses based on body weight; rely on systematic titration instead. 1
  • Approximately 70 % of children respond to methylphenidate when the full dose range is tried. 1
  • Infrequent monitoring in community settings leads to inferior outcomes compared with optimal medication management. 1

Expected Response Patterns

  • More than 90 % of patients will respond to at least one stimulant class (methylphenidate or amphetamine) when both are systematically trialed. 1
  • Response to one stimulant does not predict response to another; separate trials are necessary. 2

Maintenance Phase Monitoring

  • After establishing the optimal dose, schedule monthly follow‑up appointments until symptoms are stable, then transition to quarterly monitoring. 1
  • Reassess medication efficacy at regular intervals using standardized rating scales. 1
  • Monitor for emergence of adverse effects such as tics, mood changes, and social withdrawal. 1
  • Be prepared to adjust doses as needed; optimal medication management requires ongoing titration over time. 1